Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2022 | $7.75 → $7.25 | Neutral | Cantor Fitzgerald |
| 12/10/2021 | $8.75 → $7.75 | Neutral | Cantor Fitzgerald |
| 11/23/2021 | Neutral | Cantor Fitzgerald | |
| 11/23/2021 | $8.75 | Neutral | Cantor Fitzgerald |
| 9/13/2021 | $12.00 | Buy | ROTH Capital |
| 9/3/2021 | Buy | Desjardins | |
| 9/3/2021 | $15.00 | Buy | Desjardins |
6-K - High Tide Inc. (0001847409) (Filer)
6-K - High Tide Inc. (0001847409) (Filer)
6-K - High Tide Inc. (0001847409) (Filer)
CALGARY, AB, July 15, 2026 /CNW/ -- High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce that Founder & Chief Executive Officer Raj Grover answered shareholder questions during his fifth Reddit Ask Me Anything ("AMA") session today, on July 15, 2026, on the Company's official subreddit, r/HighTideInc. The AMA continues High Tide's long-standing commitment to direct, unfiltered engagement with its retail shareholder base, a community that has been central to the C
CALGARY, AB, July 6, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its board of directors (the "Board") has approved the adoption of a shareholder rights plan agreement (the "Temporary Shareholder Rights Plan"), and an amended and restated shareholder rights plan (the "Amended and Restated Shareholder Rights Plan", and together with the Temporary Shareholder Rights Plan, the "Plans") pursuant to agreements entered into with Olympia Trust Company, as Rights Agent, dated June 26, 2026. The Amended and Restated
CALGARY, AB, June 17, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its majority-owned subsidiary, Remexian Pharma GmbH ("Remexian"), showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026, one of Europe's largest cannabis trade shows, held June 11–14, 2026, in Berlin, Germany. Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to German patients and pharmacies, further strengthening its
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously
Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral
CALGARY, AB, March 4, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, today announced they have joined the National Compassionate Care Council (NCCC) as founding members. "Federal cannabis policy in the United States is entering a meaningful transition," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Through our experience building
CALGARY, AB, March 3, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today changes to its Board of Directors (the "Board") as part of a planned board renewal process. Board TransitionsThe Company announces that Nitin Kaushal and Andrea Elliott have resigned from the Board, effective March 2, 2026. On behalf of the Board and management, the Company thanks Mr. Kaushal, on the board since 2018, and Ms. Elliott,
Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase
The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis
Canna Cabana Remains the Largest Cannabis Retailer in Canada with 220 Current Locations The Company Reiterates its Long-Term Goal to Exceed 350 Locations Across CanadaThe Company Generated $2.9 Million in Free Cash Flow During the Quarter, Marking Significant Improvements Year Over Year and Sequentially. Over the Past 12 Months, the Company Has Generated $16.8 Million in Free Cash FlowCanadian Cabana Club Members Now Exceed 2.58 Million, Up 47% Year Over Year, Marking the Fastest Pace in 10 Quarters and Remains the Largest Cannabis Loyalty Program GloballyELITE Members in Canada Have Surpassed 162,000, Up 100% Year Over YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Re
The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21